Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.
about
Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastasesPotential applications of imaging and image-guided radiotherapy for brain metastases and glioblastoma to improve patient quality of lifeDiffusion imaging for therapy response assessment of brain tumorSurvival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.Resection versus radiosurgery for patients with brain metastases.A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanomaResults of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis.Whole brain radiation therapy in management of brain metastasis: results and prognostic factors.Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery.Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T.Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study.Prognostic indices for brain metastases--usefulness and challengesPresentation and outcome in cancer patients with extensive spread to the brain.DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients.Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers.Brain metastases from colorectal carcinoma: prognostic factors and outcome.Brain metastases from hepatocellular carcinoma: recent advances and future avenuesEvaluation of results of linac-based radiosurgery for brain metastases from primary lung cancer.A comparison of radiotherapy with radiotherapy plus surgery for brain metastases from urinary bladder cancer: analysis of 62 patients.Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA).Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.Brain metastases from colorectal carcinoma: a description of 60 cases in a single Chinese cancer center.The impact of tumour histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients.A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy.Role of radiation therapy in palliative care of the patient with cancer.Adjuvant whole-brain radiation therapy after surgical resection of single brain metastases.A nomogram for individualized estimation of survival among patients with brain metastasisDistress, anxiety and depression in patients with brain metastases before and after radiotherapy.Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastasesEGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastasesRole of efaproxiral in metastatic brain tumors.SNPs in the TGF-β signaling pathway are associated with increased risk of brain metastasis in patients with non-small-cell lung cancerPhase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.Recursive partitioning analysis classification and graded prognostic assessment for non-small cell lung cancer patients with brain metastasis: a retrospective cohort study.Therapeutic effect of gamma knife radiosurgery for multiple brain metastases.
P2860
Q26768667-9B80A399-08BE-4120-B0E9-D02B7A866E9DQ26830580-05EEF293-DBE2-4CFD-819C-5DD61A72BDC2Q30437277-65A8D478-A765-41A7-8378-7681595EB2E0Q31051761-EC628B41-5F97-4805-BE25-72F96C6E9E21Q31097790-E2655BC5-8CF7-4BE7-8004-751AAD0CF008Q33205742-2A92C0A7-FA64-4B5B-BF35-3071C54016D7Q33222212-9136F9FC-0F3A-4971-B22F-6C0B8DCAD0B3Q33248391-8C4ACB3B-6312-417F-A124-C9F30F2A3708Q33286060-0751E266-29A0-4DFD-95D3-B9FA99105CF8Q33292251-191C153C-EDF2-424D-A6B9-DBC97E8944FCQ33375710-61FA3043-A8FF-403C-96E7-8BDB42A554F2Q33386298-5214BEBC-9AC6-4123-997B-B20D77B4C1BEQ33414874-1F0C9F3E-754D-4CE0-A636-7047DF9794ECQ33517956-F24ADAA8-B6C9-4C7C-8CEA-102807056065Q33529158-D1AC550A-1D92-46AE-825E-9E831E505D2FQ33532191-1F5C3E30-7DE8-4FE2-8D4B-CC9D27AC1F62Q33550864-8E55F951-FD04-43F3-9FF7-5591410E6EE1Q33577959-89B75A9E-7E5A-444D-8C7C-941768B17948Q33649050-3A58EAC2-FA82-4C91-9B6D-0B43C4AD28F9Q33751488-5EDCD60C-BF36-41AD-8839-6F4FBCFE7D94Q33755887-2BEA8947-50CD-407E-B740-3CEAD51CB388Q33777436-51D8245C-7A05-4F35-ACF7-1D4AF3F1A2D3Q33832902-E67B5616-65D5-46CE-A1BB-9DB3C7266BBBQ33834894-682EEF13-E014-4423-BFF6-61EBFA3AD9D4Q33874796-895E8950-F866-4974-B0B1-23A1E010BC9DQ33954557-4FCCE0A7-82D5-4D6E-8242-53C3C20ED6C2Q34018126-283E8313-D95C-4B41-9FFE-602615527568Q34054681-E94B52B3-EB69-4E49-99D2-C44E2B53C993Q34061998-289893DD-AE95-4165-B09D-75006A1A226DQ34124307-D3E18DCE-FC06-4C03-8CAD-430575352703Q34132976-0DB8F0C8-360B-4E28-9F4D-D04FDC832730Q34250819-C633D3ED-736C-4660-AD35-2A64B07C634EQ34318753-C05ED424-6E10-4F52-B27B-D5CCA6487F73Q34332364-7B109D69-80AF-48DF-9B80-CA93A33597F6Q34461771-C27B702B-3AB1-4150-9176-A7897D1E7BA2Q34513604-0399A567-0491-4AC1-84E6-24185CFDDBDFQ34532211-1450A487-C403-452F-84A4-61E614437E7FQ34599885-D10C9A15-B49E-4B3D-A473-50E0658DF6C9Q34610766-68B59CC7-0F66-4BB0-A328-28A5EA9ADF84Q35555796-0F505131-E4B4-4DD9-9B62-FFB1CDDA5CD3
P2860
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Validation of the RTOG recursi ...... fication for brain metastases.
@ast
Validation of the RTOG recursi ...... fication for brain metastases.
@en
type
label
Validation of the RTOG recursi ...... fication for brain metastases.
@ast
Validation of the RTOG recursi ...... fication for brain metastases.
@en
prefLabel
Validation of the RTOG recursi ...... fication for brain metastases.
@ast
Validation of the RTOG recursi ...... fication for brain metastases.
@en
P2093
P1476
Validation of the RTOG recursi ...... fication for brain metastases.
@en
P2093
P304
P356
10.1016/S0360-3016(00)00547-2
P407
P577
2000-07-01T00:00:00Z